For investigators, site staff and study partners. NervGen posts external communications here as they are released: press releases, ClinicalTrials.gov updates, investigator newsletters and site resources. Items appear after sponsor approval and stay available for the life of the study.
The first participant has been randomized in RESTORE. Thank you to every site team for the work that made this possible and to the sites preparing to open. A press release and a ClinicalTrials.gov status update will follow and be posted under Press & Registry.
Investigators and coordinators from all participating sites will meet in Chicago in November. Agenda, travel details and registration will be sent to each site and posted here. Meeting materials will be available under Site Resources afterwards.
This hub is where NervGen will post sponsor communications for the study. Bookmark it, and use the study mailbox for anything you cannot find here.
